Flinn, I. W., Burke, J. M., Sharman, J. P., Anz, B. M., Zuniga, R., Tun, A. M., Jani, P., Biondo, J. M., Wu, M., Mun, Y., Chopra, V. S., Farighi, R., Lin, T., Villasboas, J. C., Budde, L. E. (2025). Fixed duration subcutaneous (SC) mosunetuzumab (Mosun) in patients with previously untreated high-tumor burden follicular lymphoma (FL): Interim results from the phase II MorningSun study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7014